Pharmacodynamic (PD) responses describe the interaction between a drug and its biological target, culminating in a physiological effect. These responses can be classified into different types: continuous variables, such as blood glucose levels; categorical outcomes, like survival rates; and time-to-event metrics, such as disease progression. Understanding and modeling PD responses are critical for optimizing drug efficacy and safety.
PD models describe the relationship between drug concentration and its pharmacological effect. These models are essential in drug development as they assist in predicting therapeutic outcomes, optimizing dosing regimens, and minimizing adverse effects. The key components of PD models include:
PD models are categorized based on their complexity. Empirical models employ mathematical equations to describe observed effects without incorporating mechanistic detail. Semi-mechanistic models incorporate some physiological or biochemical principles, while mechanistic models explicitly describe drug-receptor interactions and downstream signaling pathways.
Pharmacokinetics (PK) describes a drug's absorption, distribution, metabolism, and excretion, whereas pharmacodynamics (PD) defines its effects. PK–PD models integrate these two aspects, providing insights into optimal dosing strategies and therapeutic windows. These models help optimize therapy while reducing toxicity by correlating drug concentration with observed effects over time.
A fundamental PK–PD model is the Emax model, which describes the maximum effect (Emax) a drug can achieve. The Hill coefficient determines the steepness of the concentration-effect curve, influencing drug potency and sensitivity.
In antimicrobial therapy, PK–PD indices guide dosing strategies to maximize bacterial eradication and minimize resistance development. Three major PK–PD indices are used:
By leveraging these PK–PD principles, drug development and clinical practice can optimize therapeutic efficacy while minimizing adverse effects and resistance emergence.
Pharmacodynamic or PD responses describe drug-target interactions and their biological effects.
PD models define the drug concentration–effect relationship, aiding efficacy prediction, dose optimization, and safety assessment.
Key components include drug–target binding, biophase distribution, biosignal transduction, and response generation. While biophase concentration influences the observed response, other factors also play a role.
PD models fall into three categories empirical models, which use mathematical descriptions; semi-mechanistic models, which incorporate partial physiological integration; and mechanistic models, which explicitly describe biological interactions.
PK–PD models integrate pharmacokinetics and pharmacodynamics to optimize therapy and reduce toxicity.
The Emax model describes effect saturation, while the Hill coefficient affects response steepness.
In anti-infective therapy, PK–PD indices—like Cmax/MIC, AUC24/MIC, and T > MIC—help optimize microbial killing and dose selection.
繁體中文
